-
Je něco špatně v tomto záznamu ?
Polymorphisms in Non-coding RNA Genes and Their Targets Sites as Risk Factors of Sporadic Colorectal Cancer
P. Vodicka, B. Pardini, V. Vymetalkova, A. Naccarati,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- 3' nepřekládaná oblast genetika MeSH
- celogenomová asociační studie MeSH
- epigeneze genetická MeSH
- genetická predispozice k nemoci MeSH
- interakce genů a prostředí MeSH
- jednonukleotidový polymorfismus * MeSH
- kokarcinogeneze MeSH
- kolorektální nádory diagnóza epidemiologie genetika MeSH
- lidé MeSH
- mikro RNA genetika MeSH
- nekódující RNA genetika MeSH
- polyadenylace MeSH
- prognóza MeSH
- progrese nemoci MeSH
- regulace genové exprese u nádorů genetika MeSH
- rizikové faktory MeSH
- RNA nádorová genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Colorectal cancer (CRC) is a complex disease that develops as a consequence of both genetic and environmental risk factors in interplay with epigenetic mechanisms, such as microRNAs (miRNAs). CRC cases are predominantly sporadic in which the disease develops with no apparent hereditary syndrome. The last decade has seen the progress of genome-wide association studies (GWAS) that allowed the discovery of several genetic regions and variants associated with weak effects on sporadic CRC. Collectively these variants may enable a more accurate prediction of an individual's risk to the disease and its prognosis. However, the number of variants contributing to CRC is still not fully explored.SNPs in genes encoding the miRNA sequence or in 3'UTR regions of the corresponding binding sites may affect miRNA transcription, miRNA processing, and/or the fidelity of the miRNA-mRNA interaction. These variants could plausibly impact miRNA expression and target mRNA translation into proteins critical for cellular integrity, differentiation, and proliferation.In the present chapter, we describe the different aspects of variations related to miRNAs and other non-coding RNAs (ncRNAs) and evidence from studies investigating these candidate genetic alterations in support to their role in CRC development and progression.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17031472
- 003
- CZ-PrNML
- 005
- 20171030102101.0
- 007
- ta
- 008
- 171025s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/978-3-319-42059-2_7 $2 doi
- 035 __
- $a (PubMed)27573898
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Vodicka, Pavel $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska 1083, 142 00, Prague, Czech Republic. pvodicka@biomed.cas.cz. Institute of Biology and Medical Genetics, 1st Medical Faculty, Charles University, Albertov 4, 128 00, Prague, Czech Republic. pvodicka@biomed.cas.cz. Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, 323 00, Pilsen, Czech Republic. pvodicka@biomed.cas.cz.
- 245 10
- $a Polymorphisms in Non-coding RNA Genes and Their Targets Sites as Risk Factors of Sporadic Colorectal Cancer / $c P. Vodicka, B. Pardini, V. Vymetalkova, A. Naccarati,
- 520 9_
- $a Colorectal cancer (CRC) is a complex disease that develops as a consequence of both genetic and environmental risk factors in interplay with epigenetic mechanisms, such as microRNAs (miRNAs). CRC cases are predominantly sporadic in which the disease develops with no apparent hereditary syndrome. The last decade has seen the progress of genome-wide association studies (GWAS) that allowed the discovery of several genetic regions and variants associated with weak effects on sporadic CRC. Collectively these variants may enable a more accurate prediction of an individual's risk to the disease and its prognosis. However, the number of variants contributing to CRC is still not fully explored.SNPs in genes encoding the miRNA sequence or in 3'UTR regions of the corresponding binding sites may affect miRNA transcription, miRNA processing, and/or the fidelity of the miRNA-mRNA interaction. These variants could plausibly impact miRNA expression and target mRNA translation into proteins critical for cellular integrity, differentiation, and proliferation.In the present chapter, we describe the different aspects of variations related to miRNAs and other non-coding RNAs (ncRNAs) and evidence from studies investigating these candidate genetic alterations in support to their role in CRC development and progression.
- 650 _2
- $a 3' nepřekládaná oblast $x genetika $7 D020413
- 650 _2
- $a kokarcinogeneze $7 D003043
- 650 _2
- $a kolorektální nádory $x diagnóza $x epidemiologie $x genetika $7 D015179
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a epigeneze genetická $7 D044127
- 650 _2
- $a regulace genové exprese u nádorů $x genetika $7 D015972
- 650 _2
- $a interakce genů a prostředí $7 D059647
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a celogenomová asociační studie $7 D055106
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mikro RNA $x genetika $7 D035683
- 650 _2
- $a polyadenylace $7 D026723
- 650 12
- $a jednonukleotidový polymorfismus $7 D020641
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a RNA nádorová $x genetika $7 D012334
- 650 _2
- $a nekódující RNA $x genetika $7 D022661
- 650 _2
- $a rizikové faktory $7 D012307
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Pardini, Barbara $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska 1083, 142 00, Prague, Czech Republic. Human Genetics Foundation - Torino (HuGeF), via Nizza 52, 10126, Turin, Italy.
- 700 1_
- $a Vymetalkova, Veronika $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska 1083, 142 00, Prague, Czech Republic. Institute of Biology and Medical Genetics, 1st Medical Faculty, Charles University, Albertov 4, 128 00, Prague, Czech Republic.
- 700 1_
- $a Naccarati, Alessio $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska 1083, 142 00, Prague, Czech Republic. Human Genetics Foundation - Torino (HuGeF), via Nizza 52, 10126, Turin, Italy.
- 773 0_
- $w MED00008501 $t Advances in experimental medicine and biology $x 0065-2598 $g Roč. 937, č. - (2016), s. 123-49
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27573898 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20171025 $b ABA008
- 991 __
- $a 20171030102150 $b ABA008
- 999 __
- $a ok $b bmc $g 1255065 $s 992499
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 937 $c - $d 123-49 $i 0065-2598 $m Advances in experimental medicine and biology $n Adv Exp Med Biol $x MED00008501
- LZP __
- $a Pubmed-20171025
